Archives for April 11, 2006

← 2006

Lovenox dispute tests Momenta's nerves

By  Gregory Roumeliotis

Momenta, a US biotech company whose polysaccharide technology for the delivery and improved formulation of existing drugs promises lucrative revenues, is worried its generic version of Sanofi-Aventis's Lovenox may be in jeopardy after a US appeal...

Microfluidics showcase nanoparticle products at Interphex

By  staff reporter

Nanoparticle product provider Microfluidics has used this year's Interphex show to introduce products based on its Microfluidizer processor technology, providing solutions for laboratory and manufacturing applications that use nanoparticle measurements.

BioTools achieves first for media preparator

By  Wai Lang Chu

BioTools Swiss has made available its new media preperator for the laboratory automation industry, which claims to be the fastest processor of readily dispensable agar/nutrient medium.

New source of Tamiflu ingredient could boost production

By  Gregory Roumeliotis

American chemists have found that seeds of the sweetgum fruit contain significant amounts of shikimic acid, the main starting material for Tamiflu, in a discovery that could prove vital, as demand for the drug skyrockets amidst bird flu fears.